🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Boeing slashes jet output, eyes factory shake-up as COVID-19 hammers sales

Published 07/29/2020, 07:59 AM
Updated 07/29/2020, 04:20 PM
© Reuters. A Boeing logo is seen at the company's facility in Everett
BA
-
AIR
-

By Ankit Ajmera and Eric M. Johnson

(Reuters) - Boeing Co (N:BA) slashed production of its biggest twin-engined jets, delayed its new 777X by up to a year and began sunsetting the iconic 747 as it posted a bigger-than-expected quarterly loss dominated by the COVID pandemic on Wednesday.

The cuts mark the industry's latest effort to tackle a crisis that has decimated demand for air travel, with oversupplied wide-body models like the 787 Dreamliner and 777 plunging deeper into an existing downturn.

Boeing also remains exposed to tensions between the United States and China, which has shelved plans to buy big U.S. jets.

"Our industry and our company are weathering challenges like none we have ever experienced in our lifetimes," Chief Executive Dave Calhoun told analysts.

Boeing said it would cut 787 output to six a month in 2021 - down from a previous goal of seven and the third such cut since a year ago when output touched a record 14 a month.

It also plans to cut combined output of the 777 mini-jumbo and its new 777X sister model to two a month in 2021 from a previous goal of three, while delaying the 777X entry to service by a year to 2022, confirming a Reuters report.

Boeing shares fell 3% partly on the lower production, though analysts said it had managed to contain its cash burn, a central concern for investors.

Boeing lost an adjusted $4.79 per share, against average estimates of a loss of $2.54, according to Refinitiv IBES data.

The commercial airplanes unit was hit by $468 million in severance expenses related to plans to cut 19,000 jobs of its roughly 160,000 workforce and Boeing warned deeper cuts were possible.

"We'll have to further assess the size of our workforce," Calhoun told employees.

The financial impact of the health crisis has compounded the safety grounding of Boeing's narrow-body 737 MAX 16 months ago.

Calhoun told analysts MAX deliveries would resume in the fourth quarter, a fresh delay of several weeks that raises the prospect that its U.S. return to service could slip into 2021.

Boeing also slowed plans to lift battered MAX production, by pushing its target of 31 jets a month into 2022 from 2021.

"We still see a path to positive cash flow in 2021," CFO Greg Smith added, noting it would take a year after MAX deliveries begin to clear a backlog of around 450 parked jets.

787 FACTORY STUDY

In a further shake-up, Calhoun said Boeing was looking at whether to consolidate 787 production in one location as it cuts output.

It splits production on the 787 Dreamliner between Everett, Washington, and North Charleston, South Carolina.

That raises questions over the future of the Everett hub because the largest 787-10 can only be built in South Carolina.

Smith said Boeing would be able to return to a rate of 10-11 787s monthly at some point.

Calhoun said it was too early to predict the outcome of the study, part of a wider industrial reassessment.

The wide-body production cuts reflect fears that it could take until 2023 for air traffic to return to normal levels. Long-range routes - served by bigger jets like Boeing 787 and Airbus (PA:AIR) A350 - have been hit harder than short hops.

Industry sources said Boeing's production cuts would put pressure on Airbus to further cut its own wide-body production. Airbus declined comment ahead of earnings on Thursday.

Boeing also confirmed the last of its legendary 747 would roll out of the factory in 2022.

The easily spotted hump-topped jumbo had democratized global air travel in the 1970s and was a favorite of presidents and potentates, before it fell behind modern twin-jets.

© Reuters. A Boeing logo is seen at the company's facility in Everett

The coronavirus pandemic has added to the pain.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.